Therapeutic Potential of Selective PDE Inhibitors in Asthma

This publication has 40 references indexed in Scilit:

• Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation
  British Journal of Pharmacology, 1998
• Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.
  Journal of Clinical Investigation, 1997
• Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: A comparative study
  Journal of Allergy and Clinical Immunology, 1997
• Contribution of phosphodiesterase isozymes to the regulation of the L-type calcium current in human cardiac myocytes
  British Journal of Pharmacology, 1997
• Evidence that cyclic AMP phosphodiesterase inhibitors suppress interleukin‐2 release from murine splenocytes by interacting with a ‘low‐affinity’ phosphodiesterase 4 conformer
  British Journal of Pharmacology, 1997
• cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes.
  Journal of Clinical Investigation, 1997
• Identification of Phosphodiesterase IV Activity and Its Cyclic Adenosine Monophosphate-Dependent Up-Regulation in a Human Keratinocyte Cell Line (HaCaT)
  Journal of Investigative Dermatology, 1995
• Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages
  Clinical and Experimental Allergy, 1995
• Nitric oxide regulates the calcium current in isolated human atrial myocytes.
  Journal of Clinical Investigation, 1995
• Synergistic Effects of Interleukin 4 and Interferon-Gamma on Monocyte Phosphodiesterase Activity
  Journal of Investigative Dermatology, 1992